Polyphenolic Antioxidants Mimic the Effects of 1,4-Dihydropyridines on Neurotensin Receptor Function in PC3 Cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 1, 2004, Pages 92-101

  Carraway, Robert E ^a   Hassan, Sazzad ^a   Cochrane, David E ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 1,4 DIHYDROPYRIDINE DERIVATIVE; 4 (2 BENZYLBENZOYL) 2,5 DIMETHYL 1H PYRROLE 3 CARBOXYLIC ACID METHYL ESTER; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BUTYLATED HYDROXYANISOLE; CALCIUM CHANNEL BLOCKING AGENT; DIPHENYLIODONIUM SALT; FELODIPINE; INOSITOL PHOSPHATE; LUTEOLIN; MENADIONE; NEUROTENSIN; NEUROTENSIN RECEPTOR; NICARDIPINE; NIFEDIPINE; NIMODIPINE; OXIDOREDUCTASE INHIBITOR; POLYPHENOL DERIVATIVE; POTASSIUM CHANNEL; POTASSIUM ION; PYRIDOXINE; RESVERATROL; RIBOFLAVIN; SODIUM CHANNEL; SODIUM ION; THAPSIGARGIN; THIAMINE; UNINDEXED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANTIOXIDANTS; CALCIUM; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; DIHYDROPYRIDINES; ELECTRON-TRANSFERRING FLAVOPROTEINS; FLAVONOIDS; HUMANS; MALE; OXIDATION-REDUCTION; OXIDOREDUCTASES; PHENOLS; POTASSIUM; RECEPTORS, NEUROTENSIN; SODIUM; SULFHYDRYL COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 1642364578     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.060442     Document Type: Article

References (44)

1. Bae Ys, Kang SW, Seo MS, Baines IC Tekle E, Chock PB, and Rhee SG (1997) Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272:217-221.
2. 2+ currents in frog pituitary melanotrophs: implication of the inositol triphosphate/protein kinase C pathway. Eur J Neurosci 16:1907-1916.
3. Brar SS, Kennedy TP, Sturrock AB, Huecksteadt TP, Quinn MT, Murphy TM, Chitano P, and Hoidal JR (2002) NADPH oxidase promotes NF-KB activation and proliferation in human airway smooth muscle. Am J Physiol 282:L782-L795.
4. Brodie C and Blumberg PM (2003) Regulation of cell apoptosis by protein kinase C delta. Apoptosis 8:19-27.
5. Carraway R and Leeman SE (1976) Characterization of radioimmunoassayable neurotensin in the rat. Its differential distribution in the central nervous system, small intestine, and stomach. J Biol Chem 251:7045-7052.
6. 2+-channel blockers enhance neurotensin (NT) binding and inhibit NT-induced inositol phosphate formation in prostate cancer PC3 cells. J Pharm Exp Ther 307:640-650.
7. Carraway RE, Mitra SP, and Honeyman TW (1993) Effects of GTP analogs and metal ions on the binding of neurotensin to porcine brain membranes. Peptides 14:37-45.
8. 2+ channels. Annu Rev Cell Dev Biol 16:521-555.
9. De Waard M, Liu H, Walker D, Scott VES, Gurnett CA, and Cambell KP (1997) Direct binding of G-protein βγ complex to voltage-dependent calcium channels. Nature (Lond) 385:446-450.
10. +3/ascorbate-stimulated lipid peroxidation in rat brain slices. Gen Pharmacol 31:385-391.
11. Ferriola PC, Cody V, and Middleton E Jr (1989) Protein kinase C inhibition by plant flavonoids: kinetic mechanism and structure activity relationships. Biochem Pharmacol 38:1617-1624.
12. Ferris CF (1989) Neurotensin, in Gastrointestinal System II (Schultz SG and Makhlouf GM eds) pp 559-586, Oxford University Press, New York.
13. 2+ stores depletion, is mediated by arachidonic acid. Cell Calcium 24:293-304.
14. Golba KS, Deja M, Imiolek P, Kotyla PJ, Biernat J, Wos S, and Herman ZS (1995) The dihydropyridines modulate neurotensin inotropic action paradoxically. J Physiol Pharmacol 46:419-427.
15. Grazzini E, Durroux T, Payet MD, Bilodeau L, Gallo-Payet N, and Guillon G (1996) Membrane-delimited G protein-mediated coupling between Vla vasopressin receptor and dihydropyridine binding sites in rat glomerulosa cells. Mol Pharmacol 50:1273-1283.
16. Harper JL, Camerini-Otero CS, Li A, Kim S, Jacobson KA, and Daly JW (2003) Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells. Biochem Pharmacol 65:329-338.
17. Hatano N, Ohya S, Muraki K, Giles W, and Imaizumi Y (2003) Dihydropyridine Ca2+ channel antagonists and agonists block Kv4.2, Kv4.3 and Kv1.4 K+ channels expressed in HEK293 cells. Br J Pharmacol 139:533-544.
18. Hendricks JJ, de Vries HE, van der Pol SMA, van den Berg TK, van Tol EAF, and Dijkstra CD (2003) Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study. Biochem Pharmacol 65:877-885.
19. Hermans E and Maloteaux JM (1998) Mechanisms of regulation of neurotensin receptors. Pharmacol Ther 79:89-104.
20. Janero DR and Burghardt B (1989) Antiperoxidant effects of dihydropyridine calcium antagonists. Biochem Pharmacol 38:4344-4348.
21. Kamata H and Hirata H (1998) Redox regulation of cellular signalling. Cell Signal 11:1-14.
22. Lassegue B and Clempus RE (2003) Vascular NAD(P)H oxidases: specific features, expression and regulation. Am J Physiol 285:R277-R297.
23. Lehninger AL (1982) Electron transport, oxidative phosphorylation and regulation of ATP production, in Principles of Biochemistry (Anderson S and Fox J eds) pp 467-510, Worth Publishers, New York.
24. Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK, and Shi X (2003) Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun 309:1017-1026.
25. Lopez MG, Fonteriz RI, Gandia I, de la Fuente M, Villarroya M, Garcia Sanchl B, and Garcia AB (1993) The nicotinic acetylcholine receptor in bovine chromaffin cell, a new target for dihydropyridines. Eur J Pharmacol 247:199-207.
26. 2+-blockers against endothelial cell oxidative injury due to combined nitric oxide and superoxide. Pharmacol Res 45:27-33.
27. Mason RP, Mak IT, Trumbore MW, and Mason PE (1999) Antioxidant properties of calcium antagonists related to membrane biophysical interactions. Am J Cardiol 84:16L-22L.
28. Mitchell JH, Gardner PT, McPhail DB, Morrice PC, Collins AR, and Duthie GG (1998) Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch Biochem Biophys 360:142-148.
29. 125I-labeled neurotensin to membranes from porcine brain. Peptides 14:185-189.
30. Mule F and Serio R (1997) Mode and mechanism of neurotensin action in rat proximal colon. Eur J Pharmacol 319:269-272.
31. Nunez-Vergara LJ, Lopez-Alarcon C, Navarrete-Encina PA, Atria AM, Camargo C, and Squella JA (2003) Electrochemical and EPR characterization of 1,4-dihydropyridines. Reactivity towards alkyl radicals. Free Radic Res 37:109-120.
32. Ortiz ME, Nunez-Vergara LJ, and Squella JA (2003) Relative reactivity of dihydropyridine derivatives to electrogenerated superoxide ion in DMSO solutions: a voltametric approach. Pharm Res (NY) 20:292-296.
33. Palma-Aguirre JA, Montoya-Cabrera MA, du Souich P, Hoyo-Vadillo C, Flores-Murrieta FJ, and Castaneda-Hernandez G (1995) Discrepancy between bioavailability and hypotensive effect of oral and sublingual nifedipine. Am J Ther 2:3-9.
34. Rice-Evans CA, Miller NJ, and Paganga G (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20:933-956.
35. Rostene WH and Alexander MJ (1997) Neurotensin and neuroendocrine regulation. Front Neuroendocrinol 18:115-173.
36. Seethalakshmi L, Mitra SP, Dobner PR, Menon M, and Carraway RE (1997) Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations. Prostate 31:183-192.
37. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, and Griendling KK (2002) Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91:406-413.
38. Solomons TWG (1994) Electrophilic aromatic substition, in Fundamentals of Organic Chemistry, 4th ed., pp 599-641, John Wiley & Sons, New York.
39. Triggle DJ (2003) The 1,4-dihydropyridine nucleus: a pharmacophoric template part 1. Actions at ion channels. Mini Rev Med Chem 3:217-225.
40. Trudeau LE (2000) Neurotensin regulates intracellular calcium in ventral tegmental area astrocytes: evidence for the involvement of multiple receptors. Neuroscience 91:293-302.
41. q/11 through tyrosine phosphorylation of the α subunit. Science (Wash DC) 276:1878-1881.
42. Vincent JP, Mazella J, and Kitabgi P (1999) Neurotensin and neurotensin receptors. Trends Pharmacol Sci 20:302-309.
43. Yatani A, Kunze DL, and Brown AM (1988) Effects of dihydropyridine calcium channel modulators on cardiac sodium channels. Am J Physiol 254:H140-H147.
44. 2+ channel activator, in cardiac and vascular preparations. Mol Pharmacol 40:734-741.